Mixed Connective Tissue Disease (MCTD)

Mixed Connective Tissue Disease (MCTD) is a rare autoimmune disorder that combines features of several connective tissue diseases, including lupus, scleroderma, and polymyositis. Because it shares symptoms of multiple conditions, MCTD is often referred to as an overlap syndrome, and many patients benefit from care by a specialist for mixed connective tissue disease.

In MCTD, the immune system mistakenly attacks the body’s own tissues, leading to chronic inflammation that can affect the joints, skin, muscles, and internal organs such as the lungs, heart, and kidneys.  Symptoms and severity can vary significantly from person to person, which is why individualized care, timely mixed connective tissue disease diagnosis, and early treatment appointments are important for long-term health.

​

Common Signs and Symptoms of MCTD

Mixed connective tissue disease symptoms may develop gradually and often overlap with other autoimmune conditions. Common symptoms include:

• Raynaud’s phenomenon (fingers or toes turning white or blue in cold or stress)

• Swollen hands and fingers (“puffy fingers”)

• Joint pain or inflammatory arthritis

• Muscle weakness

• Chronic fatigue

• Skin thickening or tightness

• Difficulty swallowing or heartburn

• Shortness of breath, which may indicate lung involvement
   

Because mixed connective tissue disease symptoms can change over time, ongoing medical evaluation is essential.

 

Causes and Risk Factors

The exact cause of MCTD is unknown, but it is believed to result from a combination of genetic predisposition and environmental triggers.

MCTD is:

• More common in women

• Most often diagnosed between the ages of 20 and 50

• Associated with specific autoimmune antibodies

Early evaluation by a specialist for mixed connective tissue disease can help identify the condition before complications develop.

​

How Is Mixed Connective Tissue Disease Diagnosed?

There is no single test that confirms MCTD. Mixed connective tissue disease diagnosis is based on a combination of:

• Detailed clinical symptoms and physical examination

• Blood tests showing positive anti-U1 RNP antibodies, a hallmark of MCTD

• Tests to evaluate inflammation and organ function

• Imaging or specialized studies to assess lung, heart, or kidney involvement
   

Accurate diagnosis often requires assessment by a rheumatologist experienced in autoimmune overlap syndromes.

 

Treatment and Management of MCTD

There is no cure for MCTD, but treatment focuses on reducing inflammation, managing symptoms, and preventing organ damage. Mixed connective tissue disease treatment in Orlando is tailored to each patient and may include:

• NSAIDs for joint pain and inflammation

• Corticosteroids to control disease flares

• Immunosuppressive medications, such as methotrexate or azathioprine

• Medications targeting specific complications, such as blood pressure treatments for pulmonary hypertension
   

Regular monitoring with a specialist for mixed connective tissue disease allows treatment adjustments as symptoms change.
 

Why Early Treatment Matters

Early diagnosis and treatment can help reduce symptoms, slow disease progression, and prevent damage to organs such as the lungs, heart, or kidneys.

​

Frequently Asked Questions 
 

1. What is Mixed Connective Tissue Disease?
MCTD is a rare autoimmune condition that combines features of lupus, scleroderma, and polymyositis, causing inflammation of the joints, muscles, skin, and internal organs.
 

2. What are the early symptoms of MCTD?
Early mixed connective tissue disease symptoms often include Raynaud’s phenomenon, swollen fingers, joint pain, fatigue, and muscle weakness.
 

3. How is MCTD different from lupus or scleroderma?
MCTD involves overlapping features of multiple connective tissue diseases and is identified by the presence of anti-U1 RNP antibodies.
 

4. How is MCTD treated?
Mixed connective tissue disease treatment in Orlando may include anti-inflammatory medications, corticosteroids, immunosuppressants, and targeted therapies, guided through regular treatment appointments.
 

5. When should I schedule an appointment for MCTD?
You should schedule a rheumatology appointment if you have persistent joint pain, Raynaud’s symptoms, muscle weakness, or abnormal autoimmune blood tests suggesting MCTD.